Success Metrics

Clinical Success Rate
90.7%

Based on 68 completed trials

Completion Rate
91%(68/75)
Active Trials
19(15%)
Results Posted
35%(24 trials)
Terminated
7(6%)

Phase Distribution

Ph not_applicable
45
35%
Ph phase_3
2
2%
Ph early_phase_1
1
1%
Ph phase_1
13
10%
Ph phase_2
14
11%
Ph phase_4
1
1%

Phase Distribution

14

Early Stage

14

Mid Stage

3

Late Stage

Phase Distribution76 total trials
Early Phase 1First-in-human
1(1.3%)
Phase 1Safety & dosage
13(17.1%)
Phase 2Efficacy & side effects
14(18.4%)
Phase 3Large-scale testing
2(2.6%)
Phase 4Post-market surveillance
1(1.3%)
N/ANon-phased studies
45(59.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.2%

68 of 78 finished

Non-Completion Rate

12.8%

10 ended early

Currently Active

19

trials recruiting

Total Trials

127

all time

Status Distribution
Active(31)
Completed(68)
Terminated(10)
Other(18)

Detailed Status

Completed68
unknown18
Recruiting15
Not yet recruiting12
Terminated7
Active, not recruiting4

Development Timeline

Analytics

Development Status

Total Trials
127
Active
19
Success Rate
90.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (1.3%)
Phase 113 (17.1%)
Phase 214 (18.4%)
Phase 32 (2.6%)
Phase 41 (1.3%)
N/A45 (59.2%)

Trials by Status

completed6854%
withdrawn32%
active_not_recruiting43%
terminated76%
unknown1814%
not_yet_recruiting129%
recruiting1512%

Recent Activity

Clinical Trials (127)

Showing 20 of 127 trialsScroll for more
NCT02019706Phase 2

Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome

Recruiting
NCT06985914

Retrospective Study of CT Scan Indications in Adult Emergency Departments

Completed
NCT07685028Not Applicable

LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol A

Not Yet Recruiting
NCT02088775Not Applicable

PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer

Completed
NCT06833502Phase 2

Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer

Recruiting
NCT02769962Phase 1

Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer

Completed
NCT07648329

Association Between Circulating BDNF Levels and Atrial Cardiomyopathy in Patients Undergoing Ablation for Persistent Atrial Fibrillation

Not Yet Recruiting
NCT06199479Phase 1

Radiologic Pathologic Correlation of Imaging to Distinguish True Progression From Pseudoprogression in Brain Malignancies

Recruiting
NCT07192133Phase 2

Evaluation of CT-XPI

Recruiting
NCT07632092

Early [18F]-FDG PET Dynamic Analysis in Brain Metastases After Radiotherapy.

Recruiting
NCT07600801

LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol B

Not Yet Recruiting
NCT04432597Phase 1

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

Active Not Recruiting
NCT06673329Phase 1

Brodalumab in the Treatment of Immune-Related Adverse Events

Recruiting
NCT07417488Phase 1

GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas

Recruiting
NCT04451980

The HIV, Adipose Tissue Immunology, and Metabolism Study

Completed
NCT03038568

Assessing How Normal Variations in CT Scanning Affects Its Interpretation

Active Not Recruiting
NCT04716907

Thymic Function in Patients With COVID-19

Completed
NCT07475260

SVF-Treo Study: Influence of Cardiac and Respiratory Pulsatility Deformation

Not Yet Recruiting
NCT07433309

CT Body Composition as Predictor of Exercise Therapy Outcome in Peripheral Arterial Disease

Not Yet Recruiting
NCT03097276Not Applicable

Management of Patients With High C-reactive Protein After Scheduled Resection of Colorectal Cancer

Completed

Drug Details

Intervention Type
RADIATION
Total Trials
127